SCHEMBL4787833

SCHEMBL4787833

Cc1ccc(Sc2ccc(S(=O)(=O)N3CCc4ccc(Cl)cc4C3)c3nonc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.40
IDO1 P14902 3/20 0.40
ACLY P53396 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AKR1C1 Q04828 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
POLB P06746 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
LMNA P02545 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPK1 P28482 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787181 0.87 PKM (0.42) AKR1C3IDO1ALDH1A1MEN1KMT2A
SCHEMBL4786646 0.85 AKR1C3 (0.41) AKR1C3IDO1ALDH1A1MEN1KMT2A
SCHEMBL4788040 0.82 SMN1; SMN2 (0.41) AKR1C3ALDH1A1MEN1KMT2AAKR1C1
SCHEMBL4788142 0.81 ESR1 (0.50) AKR1C3IDO1ACLYTMEM97SIGMAR1
SCHEMBL4787281 0.81 AKR1C3 (0.47) AKR1C3ACLYTMEM97SIGMAR1ALDH1A1
SCHEMBL4787836 0.77 AKR1C3 (0.47) AKR1C3ACLYALDH1A1MEN1KMT2A
SCHEMBL4787292 0.75 KMT2A (0.46) IDO1ALDH1A1MEN1KMT2APOLB
SCHEMBL4787431 0.74 IDO1 (0.47) IDO1ALDH1A1MEN1KMT2APOLB
SCHEMBL5243352 0.70 KMT2A (0.43) IDO1ALDH1A1MEN1KMT2APOLB
SCHEMBL8160491 0.70 ACLY (0.50) ACLYALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008115259-A2 DERIVATIVES OF BENZOXADIAZOLE SUITABLE FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES RIGEL PHARMACEUTICALS, INC. (US) 2008-09-25 WO claimed